US20170086753A1 - Vital signs sensor and method of measuring vital signs of a user - Google Patents

Vital signs sensor and method of measuring vital signs of a user Download PDF

Info

Publication number
US20170086753A1
US20170086753A1 US15/278,317 US201615278317A US2017086753A1 US 20170086753 A1 US20170086753 A1 US 20170086753A1 US 201615278317 A US201615278317 A US 201615278317A US 2017086753 A1 US2017086753 A1 US 2017086753A1
Authority
US
United States
Prior art keywords
light
wavelength
user
wavelengths
vital signs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/278,317
Inventor
Cristian Nicolae Presura
Andrei Nicolae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Philips NV
Original Assignee
Koninklijke Philips N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Philips N.V. filed Critical Koninklijke Philips N.V.
Publication of US20170086753A1 publication Critical patent/US20170086753A1/en
Assigned to KONINKLIJKE PHILIPS N.V. reassignment KONINKLIJKE PHILIPS N.V. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NICOLAE, Andrei, PRESURA, CRISTIAN NICOLAE
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024Detecting, measuring or recording pulse rate or heart rate
    • A61B5/02416Detecting, measuring or recording pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
    • A61B5/02427Details of sensor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7203Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
    • A61B5/7207Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts
    • A61B5/7214Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts using signal cancellation, e.g. based on input of two identical physiological sensors spaced apart, or based on two signals derived from the same sensor, for different optical wavelengths
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0233Special features of optical sensors or probes classified in A61B5/00
    • A61B2562/0238Optical sensor arrangements for performing transmission measurements on body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026Measuring blood flow
    • A61B5/0261Measuring blood flow using optical means, e.g. infrared light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026Measuring blood flow
    • A61B5/0295Measuring blood flow using plethysmography, i.e. measuring the variations in the volume of a body part as modified by the circulation of blood therethrough, e.g. impedance plethysmography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases

Definitions

  • Various embodiments relate to a vital signs sensor as well as to a method of measuring vital signs of a user.
  • Optical heart rate sensors are well known to monitor or detect vital signs like a heart rate of a user.
  • a heart rate sensor can be based on a photoplethysmographic (PPG) sensor and can be used to acquire a volumetric organ measurement.
  • PPG photoplethysmographic
  • the PPG sensors comprise a light source like a light emitting diode (LED) which is emitting light into the skin of a user. The emitted light is scattered in the skin and is at least partially absorbed by the blood. Part of the light exits the skin and can be captured by a photo detector.
  • LED light emitting diode
  • the amount of light that is captured by the photo detector can be an indication of the blood volume inside the skin of a user.
  • a PPG sensor can thus monitor the perfusion of blood in the dermis and subcutaneous tissue of the skin through an absorption measurement at a specific wave length. If the blood volume is changed due to the pulsating heart, the scattered light coming back from the skin of the user is also changing. Therefore, by monitoring the detected light signal by means of the photo detector, a pulse of a user in his skin and thus the heart rate can be determined. Furthermore, compounds of the blood like oxygenated or de-oxygenated hemoglobin as well as oxygen saturation can be determined, when at least two colors are used.
  • the pulse signal of a heart beat can be detected by photoplethysmography PPG which is measuring a variation in the blood volume of the human tissue.
  • PPG photoplethysmography
  • light emitting diodes e.g. at wavelengths between 520 nm (green) and 850 nm (infrared) are used to emit light onto the skin of a user.
  • Transmission type PPG measurements are performed with light at wavelength ranges of 650-850 nm while reflective type PPG sensing is used at 520-570 nm.
  • the output signal of the photo diode can therefore be an indication of the blood volume as well as the variation of the blood volume, i.e. the pulse in the skin of a user.
  • FIG. 1 shows a graph indicating an output signal of a PPG sensor according to the prior art without a movement.
  • the heart rate or pulse signal is clearly detectable.
  • the output signal of the PPG sensor can be distorted.
  • FIG. 2 shows an output signal of a PPG sensor according to the prior art without a motion and in the presence of motion.
  • the output voltage V of the PPG sensor is depicted over time.
  • the region A 1 as well as in the region A 3 , no motion is present. Motion is, however, present in the region A 2 .
  • the pulse signals are harder to be determined.
  • a large part of the artefacts in the region A 2 is due to blood in the veins of a user as the blood pressure is smaller in the veins.
  • U.S. Pat. No. 7,727,159 B2 discloses a PPG sensor with a motion artefact correction capability.
  • Various embodiments described herein provide a vital signs sensor with an increased signal to noise ratio by eliminating motion artefacts in the output signal of the vital signs sensor.
  • an optical vital signs sensor is provided to measure or determine vital signs of a user.
  • the optical vital signs sensor can be a photoplethysmographic sensor (PPG).
  • a light source is configured to generate at least three wavelengths which are directed towards a skin of the user.
  • the sensor also comprises a photo detector unit configured to detect an intensity of light at the at least three wavelengths, wherein said light is indicative of a reflection of light emitted in or from the skin of the user.
  • the sensor also comprises a motion correction unit configured to correct motion artefacts from the light intensity detected by the photo detector by subtracting the light intensity detected at the second wavelength from an average of the light intensity detected at the first wavelength and that at the third wavelength.
  • the first, second and third wavelengths are arranged approximately around 550 nm.
  • the second wavelength is arranged at an equidistant position or wavelengths between the first and second wavelength. As an example, the first wavelength is 530 nm, the second wavelength is 550 nm and the third wavelength is 570 n
  • the second wavelength corresponds to a sum of the first and third wavelength divided by 2. If the first, second and third wavelength is selected accordingly, this results in an easy and effective motion artefact correction.
  • the second wavelength corresponds to approximately 550 nm. Accordingly, the first wavelength may be 530 nm while the third wavelength is 570 nm. Alternatively, the first wavelength may be 540 nm while the third wavelength can be 560 nm.
  • a method of measuring or determining vital signs of a user with an optical vital signs sensor configured to measure or determine vital signs of a user is provided.
  • the optical vital signs sensor is a PPG sensor.
  • Light is generated at at least three wavelengths and is directed to what a skin of a user.
  • An intensity of light which is indicative of a reflection of light emitted in or from the skin of a user is detected at the at least three wavelengths.
  • Motion artefacts are corrected from the detected light by subtracting the light intensity detected at the second wavelength from an average of the light intensity detected at the first wavelength, and at the third wavelength,
  • the first, second and third wavelengths are arranged approximately around 550 nm.
  • the second wavelength is arranged equidistantly between the first and third wavelength.
  • a computer program for monitoring a heart rate of a user in an optical vital signs sensor as defined above comprises program code means for causing the optical vital signs sensor to carry out the steps of the method measuring or determining vital signs of a user when the computer program is run on a computer controlling the optical vital signs sensor or when the computer program is run in the optical vital signs sensor.
  • the vital signs sensor comprises a LED based PPG sensor.
  • the LED light penetrates the skin of the user, is reflected and some of it can reach a photo detector.
  • the output of the photo detector can be used to monitor a blood volume fraction and blood compounds like oxygenated and de-oxygenated hemoglobin.
  • the amount of absorption or reflectance of the light from the LED light source can be used to determine the heart rate as well as the blood volume fraction or blood compounds.
  • the heart rate relates to the blood volume fraction.
  • the PPG sensor according to various embodiments is therefore an optical sensor allowing a non-invasive measurement of vital signs of a user.
  • a PPG sensor for measuring or detecting a heart rate of a user.
  • the PPG sensor comprises at least one light source such as a LED and at least one photo detector such as photo diode.
  • the signal received by the photo diode is processed to determine the heart rate of a user.
  • a light at three different wavelengths which are equidistant from each other and which are arranged around 550 nm are emitted by the PPG sensor.
  • the output signal of the photo detector and the second wavelength is subtracted from the average output signal of the photo detector at the first and at the third wavelength.
  • FIG. 1 shows a graph of an output signal of a PPG sensor according to the prior art
  • FIG. 2 shows an output signal of a PPG sensor according to the prior art
  • FIG. 3 shows a basic representation of an operational principle of a vital signs sensor according to various embodiments
  • FIG. 4 shows a graph indication the intensity of light reflected from a skin of a user according to various embodiments
  • FIG. 5 shows a graph indicating the dependence of the amplitude of an output signal versus the wavelength of the light from a PPG sensor
  • FIG. 6 shows a graph indicating a spectrum of light reflected by blood as well as a spectrum of light reflected by the tendon of the user
  • FIG. 7 shows a block diagram of an optical vital signs sensor according to various embodiments.
  • FIG. 8 shows a graph of the output signal of a PPG sensor without and with a motion correction according to various embodiments.
  • FIG. 3 shows a basic representation of an operational principle of a vital signs sensor.
  • a heart rate sensor 100 with its contact surface 101 is arranged or placed on for example an arm of a user.
  • the vital signs sensor can be based on a photoplethysmograph PPG sensor.
  • the contact surface 101 can be directly placed onto the skin 1000 of the user.
  • the heart rate sensor 100 comprises at least one light source 110 and at least one photo detector 120 .
  • the light source 110 emits light e.g. via the contact surface 101 onto or in the skin 1000 of a user. Some of the light is reflected and the reflected light can be detected by the photo detector 120 . Some light can be transmitted through tissue of the user and be detected by the photo detector 120 .
  • a motion correction unit 130 is configured to correct motion artefacts from the output of the at least one photo detector 120 to improve the signal-to-noise ration and to determine a heart rate or other vital signs of the user.
  • the output signal of the PPG sensor gives an indication on the blood movement in vessels of a user.
  • the quality of the output signal of the PPG sensor can depend on the blood flow rate, skin morphology and skin temperature.
  • optical losses in the PPG sensor may also have an influence on the quality of the output signal of the PPG sensor.
  • the optical efficiency of the PPG sensor can depend on reflection losses when light penetrates from one media into another. Furthermore, scattering of light at the surface of the skin of the user may also have an influence on the optical efficiency of the PPG sensor.
  • the PPG sensor or optical vital signs sensor can be implemented as a wrist device (like a watch or smart watch).
  • the optical vital signs sensor can also be implemented as a device worn behind the ear of a user, e.g. like a hearing aid.
  • the PPG sensor can also be implemented as non-invasive sensor, a non-contact or contact-less sensor.
  • a contact-less sensor can comprise at least two (non-contact) optical fibers (one optical fiber as transmitter or light source and one optical fiber as receiver) and can be used to detect the vital signs of a user.
  • FIG. 4 shows a graph indicating the intensity of light reflected from a skin of a user according to various embodiments.
  • a spectrum of light I as reflected from a skin 1000 of a user is depicted over the wavelength W (nm).
  • W nm
  • the amplitude of the reflected light can change due to the pulsation of blood as well as the movement of the user or a relative movement of the PPG sensor and the user.
  • FIG. 5 shows a graph indicating the dependence of the amplitude PA of an output signal versus the wavelength W (nm) of the light from a PPG sensor.
  • W wavelength
  • the amplitude of the pulses are in particular high and distinct at wavelengths around 550 nm.
  • FIG. 6 shows a graph indicating a spectrum of light reflected by blood as well as a spectrum of light reflected by the tendon of the user.
  • the upper curve shows the dependence on the spectrum of light I as reflected by the blood of a user.
  • the lower curve shows a spectrum of light I as reflected by the tendon of a user. While the light as reflected by the blood has two distinct peaks, the light as reflected by the tendon has an approximate linear decline with increasing wavelength W (nm).
  • FIG. 7 shows a block diagram of an optical vital signs sensor according to various embodiments.
  • the optical vital signs sensor 100 may comprise a contact surface 101 which can be placed in direct contact with the skin 1000 of a user.
  • the optical vital signs sensor comprises a light unit 110 which can have three light emitting diodes 111 - 113 . These three light emitting diodes 111 - 113 may emit light 111 a , 112 a , 113 a at three different wavelengths.
  • the light unit 110 may also comprise one tunable light emitting diode which can emit light 111 a , 112 a , 113 a at three different wavelengths.
  • the optical vital signs sensor 100 furthermore comprises a photo detector unit 120 which is able to detect the reflected light 121 a - 123 c .
  • the light unit 110 can be able to emit light 111 a - 113 a at three wavelengths.
  • the photo detector 120 may comprise three different photo diodes 121 - 123 which are able to detect the reflected light at the three different wavelengths 121 a - 123 b .
  • the output of the photo detector 120 is forwarded to the motion correction unit 130 which is performing a motion correction on the output signals.
  • the motion correction 130 serves to remove motion artefacts from the output signal of the photo detector.
  • the three different wavelengths may be Y 1 , Y 2 and Y 3 . These three wavelengths Y 1 -Y 3 are arranged on one of the peaks around 550 nm.
  • the output signal of the photo detector is a sum of an output signal of the photo detector due to reflected light from the blood B of the user as well as reflected light from the tendons T.
  • the output signal Y bt can therefore be Y b +Y t , wherein the index “b” corresponds to blood and the index “t” corresponds to tendons. If this equation is applied to three points, the results thereof are as follows:
  • the coordinates of the three points may be members of an arithmetic series such that
  • the middle wavelength is at an equidistant position between the first and third wavelength such that
  • a motion correction can be based on the following formula:
  • the influence of the tendons can be removed such that only the reflected light due to the blood variation is determined.
  • the first wavelength Y 1 is 530 nm
  • the second wavelength Y 2 is 550 nm
  • the third wavelength Y 3 is 570 nm.
  • Other wavelengths are also possible as long as the second wavelength is equidistant to the first and third wavelength.
  • the second wavelength is arranged in the middle between the first and third wavelength.
  • FIG. 8 shows a graph of the output signal of a PPG sensor without and with a motion correction according to various embodiments.
  • a single unit or device may fulfil the functions of several items recited in the claims.
  • a computer program may be stored/distributed on a suitable medium such as an optical storage medium or a solid state medium, supplied together with or as a part of other hardware, but may also be distributed in other forms such as via the internet or other wired or wireless telecommunication systems.

Abstract

PPG sensor emits light at at least three wavelengths (Y1-Y3) and detects the reflected light. The PPG sensor comprises a motion correction unit for correcting motion artefacts from the detected light signals by subtracting the output signal of the detected light at the second wavelength (Y2) from an average of an output signal of the detected light at the first and third wavelength (Y1, Y3). The three wavelengths (Y1-Y3) are arranged around 550 nm. The second wavelength (Y2) is arranged equal distantly between the first and third wavelength.

Description

    TECHNICAL FIELD
  • Various embodiments relate to a vital signs sensor as well as to a method of measuring vital signs of a user.
  • BACKGROUND
  • Optical heart rate sensors are well known to monitor or detect vital signs like a heart rate of a user. Such a heart rate sensor can be based on a photoplethysmographic (PPG) sensor and can be used to acquire a volumetric organ measurement. By means of optical pulse sensors or pulse oximeters, changes in light absorption of a human skin are detected and based on these measurements a heart rate or other vital signs of a user can be determined. The PPG sensors comprise a light source like a light emitting diode (LED) which is emitting light into the skin of a user. The emitted light is scattered in the skin and is at least partially absorbed by the blood. Part of the light exits the skin and can be captured by a photo detector. The amount of light that is captured by the photo detector can be an indication of the blood volume inside the skin of a user. A PPG sensor can thus monitor the perfusion of blood in the dermis and subcutaneous tissue of the skin through an absorption measurement at a specific wave length. If the blood volume is changed due to the pulsating heart, the scattered light coming back from the skin of the user is also changing. Therefore, by monitoring the detected light signal by means of the photo detector, a pulse of a user in his skin and thus the heart rate can be determined. Furthermore, compounds of the blood like oxygenated or de-oxygenated hemoglobin as well as oxygen saturation can be determined, when at least two colors are used.
  • The pulse signal of a heart beat can be detected by photoplethysmography PPG which is measuring a variation in the blood volume of the human tissue. In a PPG sensor, light emitting diodes e.g. at wavelengths between 520 nm (green) and 850 nm (infrared) are used to emit light onto the skin of a user. Transmission type PPG measurements are performed with light at wavelength ranges of 650-850 nm while reflective type PPG sensing is used at 520-570 nm.
  • Light is scattered in the skin of the user and some of the light is absorbed by blood. The reflected light exits the skin and can be detected by a photo diode. The output signal of the photo diode can therefore be an indication of the blood volume as well as the variation of the blood volume, i.e. the pulse in the skin of a user.
  • FIG. 1 shows a graph indicating an output signal of a PPG sensor according to the prior art without a movement. In the graph, the heart rate or pulse signal is clearly detectable.
  • However, in the presence of movement, the output signal of the PPG sensor can be distorted.
  • FIG. 2 shows an output signal of a PPG sensor according to the prior art without a motion and in the presence of motion. In FIG. 2, the output voltage V of the PPG sensor is depicted over time. In the region A1 as well as in the region A3, no motion is present. Motion is, however, present in the region A2. As can be seen in the region A2 because of the influence of motion, the pulse signals are harder to be determined. A large part of the artefacts in the region A2 is due to blood in the veins of a user as the blood pressure is smaller in the veins.
  • U.S. Pat. No. 7,727,159 B2 discloses a PPG sensor with a motion artefact correction capability.
  • SUMMARY
  • Various embodiments described herein provide a vital signs sensor with an increased signal to noise ratio by eliminating motion artefacts in the output signal of the vital signs sensor.
  • According to various embodiments, an optical vital signs sensor is provided to measure or determine vital signs of a user. The optical vital signs sensor can be a photoplethysmographic sensor (PPG). A light source is configured to generate at least three wavelengths which are directed towards a skin of the user. The sensor also comprises a photo detector unit configured to detect an intensity of light at the at least three wavelengths, wherein said light is indicative of a reflection of light emitted in or from the skin of the user. The sensor also comprises a motion correction unit configured to correct motion artefacts from the light intensity detected by the photo detector by subtracting the light intensity detected at the second wavelength from an average of the light intensity detected at the first wavelength and that at the third wavelength. The first, second and third wavelengths are arranged approximately around 550 nm. The second wavelength is arranged at an equidistant position or wavelengths between the first and second wavelength. As an example, the first wavelength is 530 nm, the second wavelength is 550 nm and the third wavelength is 570 nm.
  • According to various embodiments, the second wavelength corresponds to a sum of the first and third wavelength divided by 2. If the first, second and third wavelength is selected accordingly, this results in an easy and effective motion artefact correction.
  • According to various embodiments, the second wavelength corresponds to approximately 550 nm. Accordingly, the first wavelength may be 530 nm while the third wavelength is 570 nm. Alternatively, the first wavelength may be 540 nm while the third wavelength can be 560 nm.
  • According to various embodiments, a method of measuring or determining vital signs of a user with an optical vital signs sensor configured to measure or determine vital signs of a user is provided. The optical vital signs sensor is a PPG sensor. Light is generated at at least three wavelengths and is directed to what a skin of a user. An intensity of light which is indicative of a reflection of light emitted in or from the skin of a user is detected at the at least three wavelengths. Motion artefacts are corrected from the detected light by subtracting the light intensity detected at the second wavelength from an average of the light intensity detected at the first wavelength, and at the third wavelength, The first, second and third wavelengths are arranged approximately around 550 nm. The second wavelength is arranged equidistantly between the first and third wavelength.
  • According to various embodiments, a computer program for monitoring a heart rate of a user in an optical vital signs sensor as defined above is provided. The computer program comprises program code means for causing the optical vital signs sensor to carry out the steps of the method measuring or determining vital signs of a user when the computer program is run on a computer controlling the optical vital signs sensor or when the computer program is run in the optical vital signs sensor.
  • According to various embodiments, the vital signs sensor comprises a LED based PPG sensor. The LED light penetrates the skin of the user, is reflected and some of it can reach a photo detector. The output of the photo detector can be used to monitor a blood volume fraction and blood compounds like oxygenated and de-oxygenated hemoglobin. In particular, the amount of absorption or reflectance of the light from the LED light source can be used to determine the heart rate as well as the blood volume fraction or blood compounds. The heart rate relates to the blood volume fraction. Furthermore, the PPG sensor according to various embodiments is therefore an optical sensor allowing a non-invasive measurement of vital signs of a user.
  • According to various embodiments a PPG sensor is provided for measuring or detecting a heart rate of a user. The PPG sensor comprises at least one light source such as a LED and at least one photo detector such as photo diode. The signal received by the photo diode is processed to determine the heart rate of a user. In order to correct any motion artifacts which were generated by a motion of the user while wearing the PPG sensor, a light at three different wavelengths which are equidistant from each other and which are arranged around 550 nm are emitted by the PPG sensor. In order to remove the motion artifacts from the output signals of the photo detector the output signal of the photo detector and the second wavelength is subtracted from the average output signal of the photo detector at the first and at the third wavelength.
  • It shall be understood that some embodiments can also be a combination of the dependent claims or above embodiments or aspects with respective independent claims.
  • These and other aspects be apparent from and elucidated with reference to the embodiment(s) described hereinafter.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • In the following drawings:
  • FIG. 1 shows a graph of an output signal of a PPG sensor according to the prior art,
  • FIG. 2 shows an output signal of a PPG sensor according to the prior art,
  • FIG. 3 shows a basic representation of an operational principle of a vital signs sensor according to various embodiments,
  • FIG. 4 shows a graph indication the intensity of light reflected from a skin of a user according to various embodiments,
  • FIG. 5 shows a graph indicating the dependence of the amplitude of an output signal versus the wavelength of the light from a PPG sensor,
  • FIG. 6 shows a graph indicating a spectrum of light reflected by blood as well as a spectrum of light reflected by the tendon of the user,
  • FIG. 7 shows a block diagram of an optical vital signs sensor according to various embodiments, and
  • FIG. 8 shows a graph of the output signal of a PPG sensor without and with a motion correction according to various embodiments.
  • DETAILED DESCRIPTION OF EMBODIMENTS
  • FIG. 3 shows a basic representation of an operational principle of a vital signs sensor. In FIG. 3, a heart rate sensor 100 with its contact surface 101 is arranged or placed on for example an arm of a user. The vital signs sensor can be based on a photoplethysmograph PPG sensor. The contact surface 101 can be directly placed onto the skin 1000 of the user. The heart rate sensor 100 comprises at least one light source 110 and at least one photo detector 120. The light source 110 emits light e.g. via the contact surface 101 onto or in the skin 1000 of a user. Some of the light is reflected and the reflected light can be detected by the photo detector 120. Some light can be transmitted through tissue of the user and be detected by the photo detector 120. Based on the reflected light, vital signs of a user like a heart rate can be determined. A motion correction unit 130 is configured to correct motion artefacts from the output of the at least one photo detector 120 to improve the signal-to-noise ration and to determine a heart rate or other vital signs of the user.
  • The output signal of the PPG sensor gives an indication on the blood movement in vessels of a user. The quality of the output signal of the PPG sensor can depend on the blood flow rate, skin morphology and skin temperature. In addition, optical losses in the PPG sensor may also have an influence on the quality of the output signal of the PPG sensor. The optical efficiency of the PPG sensor can depend on reflection losses when light penetrates from one media into another. Furthermore, scattering of light at the surface of the skin of the user may also have an influence on the optical efficiency of the PPG sensor.
  • The PPG sensor or optical vital signs sensor according to various embodiments can be implemented as a wrist device (like a watch or smart watch). The optical vital signs sensor can also be implemented as a device worn behind the ear of a user, e.g. like a hearing aid.
  • Optionally the PPG sensor according to various embodiments can also be implemented as non-invasive sensor, a non-contact or contact-less sensor. Such a contact-less sensor can comprise at least two (non-contact) optical fibers (one optical fiber as transmitter or light source and one optical fiber as receiver) and can be used to detect the vital signs of a user.
  • FIG. 4 shows a graph indicating the intensity of light reflected from a skin of a user according to various embodiments. In FIG. 4, a spectrum of light I as reflected from a skin 1000 of a user is depicted over the wavelength W (nm). However, the amplitude of the reflected light can change due to the pulsation of blood as well as the movement of the user or a relative movement of the PPG sensor and the user.
  • FIG. 5 shows a graph indicating the dependence of the amplitude PA of an output signal versus the wavelength W (nm) of the light from a PPG sensor. In FIG. 5, an amplitude of reflected light due to a motion PPG2 as well as an amplitude of reflected light due to the pulse PPG1 is depicted over the wavelength.
  • As can be seen from FIG. 5, the amplitude of the pulses are in particular high and distinct at wavelengths around 550 nm.
  • FIG. 6 shows a graph indicating a spectrum of light reflected by blood as well as a spectrum of light reflected by the tendon of the user. In FIG. 6, the upper curve shows the dependence on the spectrum of light I as reflected by the blood of a user. The lower curve shows a spectrum of light I as reflected by the tendon of a user. While the light as reflected by the blood has two distinct peaks, the light as reflected by the tendon has an approximate linear decline with increasing wavelength W (nm).
  • FIG. 7 shows a block diagram of an optical vital signs sensor according to various embodiments. The optical vital signs sensor 100 may comprise a contact surface 101 which can be placed in direct contact with the skin 1000 of a user. The optical vital signs sensor comprises a light unit 110 which can have three light emitting diodes 111-113. These three light emitting diodes 111-113 may emit light 111 a, 112 a, 113 a at three different wavelengths. Alternatively, the light unit 110 may also comprise one tunable light emitting diode which can emit light 111 a, 112 a, 113 a at three different wavelengths.
  • The optical vital signs sensor 100 furthermore comprises a photo detector unit 120 which is able to detect the reflected light 121 a-123 c. The light unit 110 can be able to emit light 111 a-113 a at three wavelengths. The photo detector 120 may comprise three different photo diodes 121-123 which are able to detect the reflected light at the three different wavelengths 121 a-123 b. The output of the photo detector 120 is forwarded to the motion correction unit 130 which is performing a motion correction on the output signals. The motion correction 130 serves to remove motion artefacts from the output signal of the photo detector.
  • The three different wavelengths may be Y1, Y2 and Y3. These three wavelengths Y1-Y3 are arranged on one of the peaks around 550 nm. According to various embodiments, the output signal of the photo detector is a sum of an output signal of the photo detector due to reflected light from the blood B of the user as well as reflected light from the tendons T. The output signal Ybt can therefore be Yb+Yt, wherein the index “b” corresponds to blood and the index “t” corresponds to tendons. If this equation is applied to three points, the results thereof are as follows:

  • Y 1bt =Y 1b +Y 1t;  (1)

  • Y 2bt =Y 2b −Y 2t;  (2)

  • Y 3bt =Y 3b +Y 3t.  (3)
  • As may be deducted from FIG. 6, the coordinates of the three points may be members of an arithmetic series such that
  • Y 1 t + Y 3 t 2 = Y 2 t . ( 4 )
  • According to various embodiments, the middle wavelength is at an equidistant position between the first and third wavelength such that
  • Y 2 = Y 1 + Y 3 2 . ( 5 )
  • According to various embodiments, a motion correction can be based on the following formula:
  • Y = Y 1 bt + Y 3 bt 2 - Y 2 bt . ( 6 )
  • If the equations 1 to 4 are substituted in the above equation, it can be seen that the influence of the tendons are removed, which results in
  • Y = Y 1 b + Y 3 b 2 - Y 2 b . ( 7 )
  • As Y1b and Y3b almost correspond to each other, the equation is as follows:

  • Y=Y 1b −Y 2b.  (8)
  • Accordingly, if this formula is used, the influence of the tendons can be removed such that only the reflected light due to the blood variation is determined.
  • As an example, the first wavelength Y1 is 530 nm, the second wavelength Y2 is 550 nm and the third wavelength Y3 is 570 nm. Other wavelengths are also possible as long as the second wavelength is equidistant to the first and third wavelength. In other words, the second wavelength is arranged in the middle between the first and third wavelength.
  • FIG. 8 shows a graph of the output signal of a PPG sensor without and with a motion correction according to various embodiments.
  • Other variations of the disclosed embodiment can be understood and effected by those skilled in the art in practicing the principles disclosed herein from a study of the drawings, the disclosure and the appended claims.
  • In the claims, the word “comprising” does not exclude other elements or steps and in the indefinite article “a” or “an” does not exclude a plurality.
  • A single unit or device may fulfil the functions of several items recited in the claims. The mere fact that certain measures are recited in mutual different dependent claims does not indicate that a combination of these measurements cannot be used to advantage. A computer program may be stored/distributed on a suitable medium such as an optical storage medium or a solid state medium, supplied together with or as a part of other hardware, but may also be distributed in other forms such as via the internet or other wired or wireless telecommunication systems.
  • Any reference signs in the claims should not be construed as limiting the scope.

Claims (6)

1. Optical vital signs sensor configured to measure vital signs of a user, comprising:
a light source configured to generate light at at least three wavelengths (Y1-Y3) which is directed towards a skin of the user, wherein the first, second and third wavelengths (Y1-Y3) are arranged approximately around 550 nm, wherein the second wavelength (Y2) is arranged equidistantly between the first and third wavelength (Y1, Y3),
at least a photo detector unit configured to detect an intensity of light at the at least three wavelengths, wherein said light is indicative of a reflection of light emitted in or from the skin of the user, and
a motion correction unit configured to correct motion artefacts from the light intensity detected by the photo detector by subtracting the light intensity detected at the second wavelength from an average of the light intensity detected at the first wavelength (Y1) and that at the third wavelength (Y3).
2. Optical vital sign sensor according to claim 1, wherein the second wavelength (Y2) corresponds to a sum of the first and third wavelength (Y1, Y3) divided by 2.
3. Optical vital sign sensor according to claim 2, wherein the second wavelength (Y2) corresponds to approximately 550 nm.
4. Optical vital sign sensor according to claim 1, wherein said optical vital signs sensor is a photoplethysmographic sensor (PPG).
5. Method of measuring vital signs of a user with an optical vital signs sensor, comprising the steps of:
generating light at at least three wavelengths (Y1-Y3) which are directed towards a skin of the user,
detecting an intensity of light at the at least three wavelengths (Y1-Y3), wherein said light is indicative of a reflection of light emitted from the skin of the user, and
correcting motion artefacts from the detected light by subtracting the light intensity detected at the second wavelength (Y2) from an average of the light intensity detected at the first wavelength (Y1), and at the third wavelength (Y3),
wherein the first, second and third wavelengths (Y1-Y3) are arranged approximately around 550 nm, and wherein the second wavelength (Y2) is arranged equidistantly between the first and third wavelength (Y1, Y3).
6. A non-transitory machine readable medium encoded with instructions for execution by a processor, the non-transitory machine readable medium comprising:
instructions for generating light at at least three wavelengths (Y1-Y3) which are directed towards a skin of the user,
instructions for detecting an intensity of light at the at least three wavelengths (Y1-Y3), wherein said light is indicative of a reflection of light emitted from the skin of the user, and
instructions for correcting motion artefacts from the detected light by subtracting the light intensity detected at the second wavelength (Y2) from an average of the light intensity detected at the first wavelength (Y1), and at the third wavelength (Y3),
wherein the first, second and third wavelengths (Y1-Y3) are arranged approximately around 550 nm, and wherein the second wavelength (Y2) is arranged equidistantly between the first and third wavelength (Y1, Y3).
US15/278,317 2015-09-28 2016-09-28 Vital signs sensor and method of measuring vital signs of a user Abandoned US20170086753A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15187156.3 2015-09-28
EP15187156 2015-09-28

Publications (1)

Publication Number Publication Date
US20170086753A1 true US20170086753A1 (en) 2017-03-30

Family

ID=54238316

Family Applications (2)

Application Number Title Priority Date Filing Date
US15/763,474 Expired - Fee Related US10376164B2 (en) 2015-09-28 2016-09-28 Vital signs sensor and method of measuring vital signs of a user
US15/278,317 Abandoned US20170086753A1 (en) 2015-09-28 2016-09-28 Vital signs sensor and method of measuring vital signs of a user

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US15/763,474 Expired - Fee Related US10376164B2 (en) 2015-09-28 2016-09-28 Vital signs sensor and method of measuring vital signs of a user

Country Status (7)

Country Link
US (2) US10376164B2 (en)
EP (1) EP3355775B1 (en)
JP (1) JP6602469B2 (en)
CN (1) CN107847167B (en)
BR (1) BR112018002192A2 (en)
RU (1) RU2680190C1 (en)
WO (1) WO2017055307A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111065326A (en) * 2017-08-25 2020-04-24 博能电子公司 Enhanced optical cardiac activity measurement
US11311242B2 (en) * 2016-05-20 2022-04-26 Sony Corporation Biological information processing apparatus, biological information processing method, and information processing apparatus
US11490863B2 (en) 2018-10-19 2022-11-08 Samsung Electronics Co., Ltd. Apparatus and method for estimating bio-information, and apparatus for supporting estimation of bio-information

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7056045B2 (en) * 2017-09-11 2022-04-19 セイコーエプソン株式会社 Detection device and biometric information measuring device
EP3613337A1 (en) * 2018-08-22 2020-02-26 Nokia Technologies Oy An apparatus, method and computer program for determining a biometric parameter
US11573351B2 (en) 2020-03-06 2023-02-07 Apple, Inc. Optical sensor having a magnetic optical barrier
US11556095B2 (en) 2020-04-15 2023-01-17 Apple Inc. Modular sensing assembly for an electronic device
SE2130200A1 (en) * 2021-07-16 2023-01-17 Rths Ab A sensing arrangement for obtaining data from a body part

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080081972A1 (en) * 2006-09-29 2008-04-03 Nellcor Puritan Bennett Incorporated Symmetric LED array for pulse oximetry
US20080171926A1 (en) * 2007-01-16 2008-07-17 Sola I Caros Josep Device for monitoring arterial oxygen saturation
US20150190063A1 (en) * 2011-10-19 2015-07-09 Biovotion Ag System for noninvasive optical measurements of physiological properties in tissue
US20150327787A1 (en) * 2013-01-24 2015-11-19 Empatica Srl Device, system and method for detection and processing of heartbeat signals
US20160249820A1 (en) * 2015-02-27 2016-09-01 Qualcomm Incorporated Estimating heart rate by tracking optical signal frequency components
US20160278674A1 (en) * 2015-03-24 2016-09-29 Covidien Lp Regional saturation system with ensemble averaging

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55120858A (en) * 1979-03-13 1980-09-17 Minolta Camera Kk Nonnvisual oxyymeter
GB9216431D0 (en) * 1992-08-01 1992-09-16 Univ Swansea Optical monitoring or measuring artefact suppression
US6842635B1 (en) * 1998-08-13 2005-01-11 Edwards Lifesciences Llc Optical device
EP1363908A4 (en) 2001-01-24 2004-05-06 Auckland Uniservices Ltd ANTI-CANCER 2,3-DIHYDRO-1H-PYRROLO 3,2-f]QUINOLINE COMPLEXES OF COBALT AND CHROMIUM
KR100763233B1 (en) 2003-08-11 2007-10-04 삼성전자주식회사 Ppg signal detecting appratus of removed motion artifact and method thereof, and stress test appratus using thereof
US7865223B1 (en) * 2005-03-14 2011-01-04 Peter Bernreuter In vivo blood spectrometry
GB0607270D0 (en) 2006-04-11 2006-05-17 Univ Nottingham The pulsing blood supply
WO2008154643A1 (en) 2007-06-12 2008-12-18 Triage Wireless, Inc. Vital sign monitor for measuring blood pressure using optical, electrical, and pressure waveforms
RU99946U1 (en) * 2010-06-09 2010-12-10 Государственное образовательное учреждение высшего профессиоанльного образования Ижевский государственный технический университет DEVICE FOR PHOTOPLETISMOGRAPHY
US8948832B2 (en) 2012-06-22 2015-02-03 Fitbit, Inc. Wearable heart rate monitor
CN104684459B (en) 2012-08-01 2017-09-12 皇家飞利浦有限公司 Motion artifacts are recognized in the measurement of photo-plethysmographic art and improve the method and system of measurement result and the reliability of alarm

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080081972A1 (en) * 2006-09-29 2008-04-03 Nellcor Puritan Bennett Incorporated Symmetric LED array for pulse oximetry
US20080171926A1 (en) * 2007-01-16 2008-07-17 Sola I Caros Josep Device for monitoring arterial oxygen saturation
US20150190063A1 (en) * 2011-10-19 2015-07-09 Biovotion Ag System for noninvasive optical measurements of physiological properties in tissue
US20150327787A1 (en) * 2013-01-24 2015-11-19 Empatica Srl Device, system and method for detection and processing of heartbeat signals
US20160249820A1 (en) * 2015-02-27 2016-09-01 Qualcomm Incorporated Estimating heart rate by tracking optical signal frequency components
US20160278674A1 (en) * 2015-03-24 2016-09-29 Covidien Lp Regional saturation system with ensemble averaging

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11311242B2 (en) * 2016-05-20 2022-04-26 Sony Corporation Biological information processing apparatus, biological information processing method, and information processing apparatus
CN111065326A (en) * 2017-08-25 2020-04-24 博能电子公司 Enhanced optical cardiac activity measurement
US11278245B2 (en) * 2017-08-25 2022-03-22 Polar Electro Oy Enhancing optical cardiac activity measurement
US11490863B2 (en) 2018-10-19 2022-11-08 Samsung Electronics Co., Ltd. Apparatus and method for estimating bio-information, and apparatus for supporting estimation of bio-information

Also Published As

Publication number Publication date
WO2017055307A1 (en) 2017-04-06
EP3355775A1 (en) 2018-08-08
BR112018002192A2 (en) 2018-09-18
JP6602469B2 (en) 2019-11-06
RU2680190C1 (en) 2019-02-18
JP2018533390A (en) 2018-11-15
EP3355775B1 (en) 2019-05-22
CN107847167A (en) 2018-03-27
US20180303358A1 (en) 2018-10-25
CN107847167B (en) 2019-04-05
US10376164B2 (en) 2019-08-13

Similar Documents

Publication Publication Date Title
US10376164B2 (en) Vital signs sensor and method of measuring vital signs of a user
US20190282107A1 (en) Optical vital signs sensor
EP2194842B1 (en) Blood oximeter
US20160058300A1 (en) Apparatus for and method of monitoring blood pressure and wearable device having function of monitoring blood pressure
US20170215747A1 (en) Optical vital signs sensor
JP6878312B2 (en) Photoelectric volumetric pulse wave recording device
US20080188728A1 (en) Method and Device for Determining the Perfusion of Blood in a Body Member
US20170347902A1 (en) Optical vital signs sensor
EP3380002A1 (en) Wearable device and system for acquiring physiological information of a subject
US20160361003A1 (en) Pulse Oximetry
US10034639B2 (en) Optical vital signs sensor
EP3125753B1 (en) Monitoring device and method for compensating non-linearity effects in vital signs monitoring
Mouradian et al. Continuous wearable health monitoring using novel PPG optical sensor and device
US20180317825A1 (en) Device and method for measuring the concentration of a chemical compound in blood
WO2016055260A1 (en) Optical vital signs sensor.
CN109788919B (en) Optical vital sign sensor
WO2017133883A1 (en) Optical vital signs sensor
WO2018146055A1 (en) Optical sensing apparatus and corresponding optical sensing method
KR20170064906A (en) Apparatus and method for measuring bio-signal
US20220211300A1 (en) Devices, Systems, and Methods Using Wearable Time Domain-Based Activity Tracker
WO2018142865A1 (en) Pulse measurement device, wearable device, and pulse measurement method

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

AS Assignment

Owner name: KONINKLIJKE PHILIPS N.V., NETHERLANDS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PRESURA, CRISTIAN NICOLAE;NICOLAE, ANDREI;SIGNING DATES FROM 20180502 TO 20190507;REEL/FRAME:049836/0197

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION